Table 2.
PanCancer studies from the TCGA collection (http://www.cbioportal.org) analyzed for CTLH gene alteration.
| No. of complete tumors analyzed | |||
|---|---|---|---|
| 1 | Lung cancer | Lung adenocarcinoma (LUAD) | 503 |
| Lung squamous cell carcinoma (LUSC) | 466 | ||
|
| |||
| 2 | Prostate cancer | Prostate adenocarcinoma (PRAD) | 487 |
|
| |||
| 3 | Breast cancer | Invasive breast carcinoma (BRCA) | 994 |
|
| |||
| 4 | Colorectal cancer | Colon adenocarcinoma (COADREAD) | 524 |
|
| |||
| 5 | Renal cancer | Kidney chromophobe (KICH) | 65 |
| Kidney renal clear cell carcinoma (KIRC) | 352 | ||
| Kidney renal papillary cell carcinoma (KIRP) | 274 | ||
|
| |||
| Total | 3665 | ||
Studies represent the top 5 most prevalent malignancies in the USA. Number of unique samples is indicated.